skip to main content

Study finds not all women get appropriate care for cervical cancer

Fewer than three out of five women with cervical cancer received guideline-based care, a new study finds. For black and Hispanic women, it’s just over half, which could help explain why cervical cancer outcomes tend to be worse for these women.

Michigan Medicine opens first prostate cancer risk clinic in the nation

It’s well known that women with certain hereditary genetic mutations, particularly BRCA1 and BRCA2, have an increased risk of breast cancer. But in recent years, researchers have discovered a link between some of those same genetic mutations – along with a handful of others – and aggressive prostate cancer.

The best treatment for laryngeal cancer? This approach helps decide

After a decade of using a novel approach to select patients for laryngeal cancer treatment, researchers are reporting "exceptional" survival rates nearing 80 percent, even for the most advanced patients.

Looking beyond cancer cells to understand what makes breast cancer spread

A new study from researchers at the University of Michigan Comprehensive Cancer Center identifies a protein in that microenvironment that promotes the spread of breast cancer cells. It’s part of a well-known family of receptors for which promising inhibitors are being developed.

Doctor communication key to managing breast cancer patient risk worries

Nearly one-third of early stage breast cancer patients overestimate their risk of cancer recurrence — believing it to be more than double their actual risk. And that overestimation is affecting their quality of life, according to two recent studies. The good news? A more nuanced approach to doctor-patient communication may help improve patients’ understanding.

Physicians fail to recommend genetic testing to many high-risk breast cancer patients

Physicians often fail to recommend genetic testing for breast cancer patients at high risk for mutations associated with ovarian and other cancers, according to a new study.

Prostate Cancer Risk Clinic

The Prostate Cancer Risk Clinic at the University of Michigan is intended for men with genetic mutations known or suspected to increase the risk of prostate cancer. Contact us: 734-647-8902

Pages